ORIGINAL CONTRIBUTION
    
PDF of Article    Article Full Text 

Home
Journal
Now in Medline / Index Medicus & ISI



Subscribe
Search
Discussion Forums
Join
Multimedia
Meeting Highlights
Lecture Presentations
Surgical Video Library
Private Lecture Series
Audio Interviews
Resources
Medline
Learning Center
Meetings
For Authors
Editorial Board
Sponsors
More Sponsors

Site News
Sign up for our newsletter:





pablo.GIF: Fisics-Incor Bovine Pericardial Bioprostheses: 15 Year Results

(#1997-RB154)

Pablo M. A. Pomerantzeff, Carlos M. A. Brandao, Paulo Cauduro, Luiz Boro Puig, Max Grinberg, Flavio Tarasoutchi, Luis F. Cardoso, Adolfo Lerner, Noedir A. G. Stolf, Geraldo Verginelli, Adib D. Jatene

Heart Institute, Hospital das Clínicas, Medical School, University of São Paulo, São Paulo, Brazil.



ABSTRACT


Background: From March 1982 to December 1995, 2,607 Fisics-Incor bovine pericardial bioprostheses were implanted in 2,259 patients. Mean age was 47.2 ± 17.5 years, and 55% were male. Rheumatic fever was present in 1,301 (45.7%) patients.

Methods: One thousand and seventy-three aortic valve replacements, 1,085 mitral replacements, 27 tricuspid replacements, 195 mitral-aortic replacements, and 16 other combined valve replacements were carried out. Combined procedures were performed in 788 (32.9%) patients, the most frequent being tricuspid valve repair (9.2%) and coronary artery bypass grafting (7.7%).

Results: Hospital mortality was 8.6% (194 patients), 8.6% for the mitral group, 4.7% for the aortic group, and 12.8% for double-valve replacements. The linear rates for calcification, thromboembolism, rupture, leak and endocarditis were, respectively, 1.1%, 0.2%, 0.9%, 0.1% and 0.5% patient-year. The actuarial survival curve was 56.7 ± 5.4% in 15 years. Survival free from endocarditis was 91.92%, survival free from thromboembolism was 95 ± 1.7%, survival free from rupture was 43.7 ± 9.8%, survival free from leak was 98.9 ± 4.5%, and survival free from calcification was 48.8 ± 7.9% in 15 years. In the late postoperative period, 1,614 (80.6%) patients were in New York Heart Association functional Class I.

Conclusions: We conclude that the results with the Fisics-Incor bovine pericardial prostheses were satisfactory in our group of patients.



AUTHOR/ARTICLE INFORMATION


Translated and reproduced with permission from Revista Brasileira De Cirurgia Cardiovascular; 12(4): 359-66. Copyright 1997 Pablo M. A. Pomerantzeff, et al.

Address correspondence and reprint requests to: Pablo M. A. Pomerantzeff, Av. Dr. Enéas de Carvalho, Aguiar, 44 - Divisão Cirúrgica, São Paulo - SP, Brazil, CEP: 05403-900

 


ISSN#: 1522-6662
Copyright 2008 Forum Multimedia Publishing, LLC. All rights reserved.

The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Forum Multimedia Publishing, LLC, assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.